Table 1.

Clinical and Demographic Data of SSc Patients

Patient	Gender+	Age (Years)	Disease Duration*(Years)	Cutaneous Subset	Lung Disease++ (Years)	ANA#Title (1:)	Scl-70&	ACA§
1	F	49	15	Diffuse	13	640	Yes	No
2	F	63	11	Limited	4	2560	Yes	No
3	F	44	16	Diffuse	12	320	No	No
4	F	49	26	Limited	8	1280	No	No
5	M	39	4	Limited	4	80	No	No
6	F	59	10	Diffuse	5	1280	Yes	No
7	F	41	8	Diffuse	6	1280	Yes	No
8	F	47	7	Diffuse	6	640	Yes	No
9	F	41	16	Diffuse	15	1280	Yes	No
10	F	23	8	Diffuse	3	160	No	No

⁺M: male; F: Female.

^*from first SSc symptom to beginning of iv CYC pulse therapy.

⁺⁺Duration of lung disease.

^#Antinuclear antibodies.

^&Scl-70: antitopoisomerase antibodies.

^§ACA: anticentromere antibodies.